BSEInsider Trading / SAST6 Aug 2026 · 6 Aug 2026, 09:05 pm
We have attached herewith intimation as per Reg. 30 of SEBI (LODR) Regulation, 2015. Kindly take the same on your record. Thank you.
Anlon Healthcare Ltd · 544497
✦ AI Summary
Anlon Healthcare Ltd has announced the closure of its trading window for dealing in securities, effective from August 6, 2026, until 48 hours after the conclusion of its Board of Directors meeting on August 11, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Anlon Healthcare Ltd - 544497 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
27831178-e800-4bd4-97d6-8200d978ad3a.pdf
View document text
August 06, 2026
To, To,
Listing Department, The National Stock Exchange of India
BSE Limited Ltd.
Phiroze Jeejeebhoy Towers, The Listing Department
Dalal Street, Exchange Plaza,
Mumbai – 400 001 Bandra – Kurla Complex,
Ref: BSE Scrip Code: 544497 Mumbai – 400051,
NSE Scrip Code: AHCL
Sub: Notice of Closure of Trading Window for Dealing in Securities of the
Company
Respected Sir/Madam,
As per Captioned subject and as per the SEBI [Prohibition of Insider Trading]
Regulations, 2015 and amendments thereto and as per policy on code of conduct for
prevention of insider trading and fair disclosure of unpublished price sensitive
information of the Company, we would like to inform you that the trading window for
dealing in the securities of the Company shall be closed for Company's Promoters &
Promoter group, Directors, Key Managerial Personnel, Designated Employees,
Connected/Designated Persons and their immediate relatives of respective persons
aforementioned with effect from Thursday, August 06, 2026 till the expiry of
Forty-Eight (48) hours from the conclusion of the Board of Directors Meeting
to be held on Tuesday, August 11, 2026.
This information is being informed to Company's Promoters & Promoter group,
Directors, Key Managerial Personnel, Designated Employees, Connected/Designated
Persons and Immediate relatives of respective persons in accordance with code of
conduct.
Accordingly, all aforesaid persons are advised not to trade in the securities of the
Company during the aforesaid period of closure of trading window.
We request you to kindly take the above on your record.
Thanking You.
For ANLON HEALTHCARE LIMITED
PUNITKUMAR RASADIA
MANAGING DIRECTOR
DIN: 06696258
ANLON HEALTHCARE LIMITED
CIN No.: L24230GJ2013PLC077543
REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road,
Rajkot-360005, Gujarat (INDIA)
PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in